Synchronous neuroendocrine tumor and non‐small‐cell lung cancer in neurofibromatosis type 1

Publisher： John Wiley & Sons Inc

E-ISSN： 2050-0904|3|12|990-996

ISSN： 2050-0904

Source： Clinical Case Reports, Vol.3, Iss.12, 2015-12, pp. : 990-996

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Erlotinib: As Maintenance Monotherapy in Non-Small-Cell Lung Cancer

By Muir Victoria J.   Dhillon Sohita  

BioDrugs, Vol. 25, Iss. 3, 2011-06 ,pp. : 139-146

Adis International

Access to resources Recommend Favorite

Prognostic role of liver X receptor‐alpha in resected stage II and III non‐small‐cell lung cancer

By  

THE CLINICAL RESPIRATORY JOURNAL, Vol. 12, Iss. 1, 2018-01 ,pp. : 241-246

John Wiley & Sons Inc

Access to resources Recommend Favorite

Radiochemotherapy for Non Small Cell Lung Cancer

By  

Current Drug Therapy, Vol. 5, Iss. 3, 2010-08 ,pp. : 180-191

Bentham Science Publishers

Access to resources Recommend Favorite

Malignant triton tumor in a patient with neurofibromatosis type 1

By Naganuma Hiroko   Funaoka Masato   Fujimori Shusei   Yoshioka Hiroshi   Hirano Hiroko   Ishida Hideaki   Komatsuda Tomoya   Yamada Mamiko   Nishikawa Yuji  

Journal of Medical Ultrasonics, Vol. 34, Iss. 2, 2007-06 ,pp. : 107-111

Springer Publishing Company

Access to resources Recommend Favorite

Diagnostic investigation of BIRC6 and SIRT1 protein expression level as potential prognostic biomarkers in patients with non‐small cell lung cancer

By  

THE CLINICAL RESPIRATORY JOURNAL, Vol. 12, Iss. 2, 2018-02 ,pp. : 633-638

John Wiley & Sons Inc

Access to resources Recommend Favorite